ArticleFrontiers in oral health2026
Solitary fibrous tumor of the sublingual gland: a case report.
Article in Frontiers in oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To emphasize the importance of considering solitary fibrous tumor (SFT) in the differential diagnosis of sublingual gland masses, particularly those presenting with unusual symptoms like tongue deviation. Methods: A case of a 41-year-old female with a painless sublingual mass and tongue deviation was analyzed. Clinical presentation, imaging, surgical management, histopathological findings, immunohistochemical results, and follow-up were systematically reviewed. Management consisted of complete surgical excision of the sublingual gland and the tumor, with preservation of the lingual and hypoglossal nerves. Results: Histopathology revealed haphazardly arranged spindle cells with characteristic staghorn-shaped blood vessels. Immunohistochemical analysis confirmed strong nuclear STAT6 and diffuse CD34 positivity, consistent with SFT. The patient remained recurrence-free at 18 months postoperatively, although tongue deviation persisted. Conclusions: sublingual gland SFTs are exceptionally rare and may mimic malignancies. Benign tumors such as SFT should be considered in the differential diagnosis of sublingual masses. Definitive diagnosis depends on histopathological and immunohistochemical confirmation. Complete surgical excision offers a favorable prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.